Nutriband Inc. (NASDAQ: NTRB), a pharmaceutical company specializing in transdermal products, announced that its Chairman and Co-Founder Serguei Melnik will present at NobleCon21, Noble Capital Markets' annual emerging growth equity conference. The presentation is scheduled for Dec. 3 at 9:30 a.m. Eastern at Florida Atlantic University's Executive Education Complex in Boca Raton, Florida. Investors and guests may attend at a discounted rate using code NTRBNOBLECON, and a high-definition webcast will be available the following day at nobleconference.com and Channelchek.com, where it will remain archived for 90 days.
This presentation is significant because Nutriband is developing an abuse-deterrent fentanyl patch incorporating its AVERSA abuse-deterrent technology. The AVERSA technology is designed to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential, such as fentanyl, a potent synthetic opioid. By presenting at a prominent emerging growth equity conference, Nutriband aims to attract investor attention and highlight the potential of its technology to address the ongoing opioid crisis. The company's focus on transdermal drug delivery systems positions it in a growing market for pain management alternatives that prioritize safety and reduce the risk of addiction.
The announcement comes as Nutriband continues to advance its pipeline of transdermal pharmaceutical products. The abuse-deterrent fentanyl patch represents a critical innovation in pain management, offering a controlled delivery mechanism that minimizes the potential for abuse. The presentation at NobleCon21 provides a platform for Melnik to discuss the company's strategy, recent developments, and future milestones. Nutriband's participation in the conference underscores its commitment to engaging with the investment community and providing transparency regarding its progress.
For more information about Nutriband and its technology, visit the company's website at www.nutriband.com. The latest news and updates relating to NTRB are available in the company's newsroom at https://nnw.fm/NTRB.
